Updated: May 18, 2026

Lukas Scheibler

APLSApellis Pharmaceuticals, Inc.SEC CIK: 0001651281
Estimated Net Worth
$5.9 Million
Last Updated: May 18, 2026 10:16 PM EST

Transaction Summary

Total Transactions43
Buy-Sell Ratio0.04
Buy Transactions1
Sell Transactions23

Transaction Volume

Total Volume-$3.11M
Net Volume$3.23M
Buy Volume$59.79K
Sell Volume-$3.17M

Trade Analysis

AVG Trade Size-$27.71K
Largest Trade$1.87M
Most Active MonthFeb
Most Active Year2022

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Lukas Scheibler has an estimated net worth of $5.9 Million. This is based on reported shares across multiple companies, which include ACUCELA INC., and Apellis Pharmaceuticals, Inc..



2017 was Lukas Scheibler's most active year for acquiring shares with 9 total transactions. Lukas Scheibler's most active month to acquire stocks was the month of December. 2022 was Lukas Scheibler's most active year for disposing of shares, totalling 21 transactions. Lukas Scheibler's most active month to dispose stocks was the month of March. 2023 saw Lukas Scheibler paying a total of $2,006,455.52 for 91,961 shares, this is the most they've acquired in one year. In 2022 Lukas Scheibler cashed out on 102,303 shares for a total of $2,431,161.36, their largest year based on trade value.

Holdings & Transactions

APLSapellis pharmaceuticals, inc.
Chief Research Officer Officer
Updated: Dec 05, 2023VIEW QUOTE
Form TypeSEC Filing
-0.0810.00K$36.92-$461.50K107.69KScheduledDec 01View
-0.031.76K$43.01-$75.53K68.30KSep 06View
0.3823.19K$58.50-$41.83K83.67KFeb 21View
-0.01678.00$51.21-$34.72K60.47KFeb 10View
-0.01542.00$52.77-$28.60K61.15KJan 27View
-0.032.02K$52.05-$104.88K61.69KJan 20View
1.4158.05K$52.66$1.87M99.18KJan 12View
-0.3623.13K$43.00-$430.00K40.36KApr 21 - 27View
-0.01609.00$36.97-$28.16K101.62KApr 05View
-0.033.50K$35.41-$151.06K102.23KApr 04View
-0.1011.50K$34.45-$473.64K105.74KApr 01View
$26.73$19.25K186.01KFeb 14View
-0.031.67K$46.80-$77.97K51.51KFeb 11View
-0.0810.68K$31.84-$393.45K118.18KFeb 10View
-0.0710.00K$29.43-$311.50K128.86KFeb 08View
-0.031.88K$38.51-$72.21K53.86KJan 28 - 31View
2.1263.00K92.68KJan 21View
$26.73$80.75K164.18KJan 21View
-0.113.42K$60.00-$205.02K26.65KJun 10View
-0.02680.00$47.72-$32.45K29.29KFeb 10View
3.1965.63K86.22KJan 28View
$26.73$199.99K158.11KDec 08View
22.3665.63K68.56KFeb 10View
85.00K85.00KFeb 08View
2.94K$20.37$59.79K2.94KMay 24View
145.00K145.00KApr 13View
View
kubota pharmaceutical holdings co ltd
EVP Research & Development Officer
Updated: Jul 18, 2017
Form TypeSEC Filing
-0.021.25K$6.50-$8.12K77.70KJul 17View
-0.021.30K$6.95-$9.03K78.95KJun 17 - 20View
-0.021.27K$6.15-$7.84K80.25KMay 17View
-0.021.32K$6.48-$8.55K81.52KApr 17View
0.054.08K$7.10-$8.87K82.84KMar 17 - 20View
0.053.88K$8.10-$11.74K84.09KFeb 17View
-0.021.48K$8.70-$12.83K85.54KJan 17 - 18View
0.054.45K$8.18-$7.20K87.02KDec 22View
-0.032.66K$9.35-$24.89K87.90KNov 17 - 21View
-1.001.77K$9.44-$16.75KNov 14View
-0.01890.00$11.48-$10.22K92.33KOct 17View
-0.032.66K$9.53-$25.38K93.22KSep 17 - 20View
-0.2531.96K$10.81-$345.51K95.89KAug 17 - 18View
120.00K120.00KJul 12View
127.85K127.85KAug 17View
View